WILLOWBROOK, Ill., April 27, 2020 /PRNewswire/ -- Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, ...

Thrombolytic agents, including tenecteplase, are generally used within 4.5 hours after the onset of stroke symptoms. Information on whether tenecteplase confers benefit beyond 4.5 hours is limited. We ...

Even patients with stroke with excellent functional recovery can experience significant, adverse nonmotor outcomes 6 months ...

The most common scale used to evaluate outcome of neurosurgical procedures, the modified rankin scale (mRS) -- does not measure what is commonly assumed, concludes a study conducted at the Department ...

The role of endovascular therapy for acute stroke with a large infarction has not been extensively studied in differing populations. We conducted a multicenter, prospective, open-label, randomized ...

In patients with acute stroke and a large infarct of unrestricted size, thrombectomy and medical care led to better functional outcomes and lower mortality compared with medical care alone, the ...